Jacob A. Frenkel
CIK: 0001237418
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Director
Discretionary Trading P&L
Holdings
About FRENKEL JACOB A
FRENKEL JACOB A (SEC CIK 0001237418) files insider reports with the SEC as Director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 3 ownership filings by FRENKEL JACOB A, all Form 4s, filed between Jan 3, 2025 and Jul 28, 2026. Those filings report 3 transactions, from Jan 1, 2025 to Jul 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FRENKEL JACOB A's filings is in NEW YORK, NY.
Recent filings by FRENKEL JACOB A
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- Pitts Peter Joe, Executive Chairman
- Lebovits Chaim, President & CEO
- Yablonka Uri, EVP & Chief Business Officer
- Patlis Alla
- ARBEL IRIT, Director
- Bairu Menghisteab, Director